CSIR Central

Development of an assay for quantification of linkage-specific O-acetylated sialoglycans on erythrocytes; its application in Indian visceral leishmaniasis

IR@IICB: CSIR-Indian Institute of Chemical Biology, Kolkata

View Archive Info
 
 
Field Value
 
Title Development of an assay for quantification of linkage-specific O-acetylated sialoglycans on erythrocytes; its application in Indian visceral leishmaniasis
 
Creator Chava, Anil Kumar
Chatterjee, Mitali
Nandi, Shyam Sundar
Mandal, Chitra
 
Subject Infectious Diseases and Immunology
 
Description We have developed a noninvasive approach for the quantification of linkage-specific 9-O-acetylated sialoglycans on mammalian erythrocytes using a lectin, Achatinin-H, whose lectinogenic epitope has previously been defined as 9-O-acetylated sialoglycoconjugates (9-O-AcSGs) a2!6 linked to subterminal GalNAc. Titration and checkerboard analysis were performed to optimize the assay using rabbit, rat and human erythrocytes that contain differing amounts of this glycotope. Assay specificity was established by decreased binding of erythrocytes to immobilised Achatinin-H when pre-incubated with excess lectin. The intra-assay coefficient of variation (CV) for rat and human erythrocytes was 8.6–9.2% and 11.1–13.0%, respectively. The inter-assay CV for rat and human erythrocytes was 9.9–10.1% and 15.2–16.6%, respectively. In previous studies, we have identified an enhanced presence of cell surface 9-O-AcSGs on the erythrocytes of patients with visceral leishmaniasis (VL) [Am. J. Trop. Med. Hyg. 58 (1998) 551]. Our assay when evaluated on erythrocytes from VL patients (n = 30) showed a fourfold increase in lectin binding as compared to endemic controls. The meanFS.E.M. of the A405 nm value was 1.14F0.04 vs. 0.23F0.03, respectively ( p < 0.0001). Following effective chemotherapy, a significant reduction of this glycotope on the erythrocytes of VL patients indicates that this assay has both a diagnostic and prognostic potential. Taken together, we conclude that this antigen-based assay is a specific and reproducible method for monitoring the disease status of VL patients and could be used in retrospective and prospective trials.
 
Publisher Elsevier
 
Date 2002
 
Type Article
PeerReviewed
 
Format application/pdf
 
Identifier http://www.eprints.iicb.res.in/769/1/JOURNAL_OF_IMMUNOLOGICAL_METHODS__Volume_270___Issue_1___Pages_1%2D10;2002[9].pdf
Chava, Anil Kumar and Chatterjee, Mitali and Nandi, Shyam Sundar and Mandal, Chitra (2002) Development of an assay for quantification of linkage-specific O-acetylated sialoglycans on erythrocytes; its application in Indian visceral leishmaniasis. Journal of Immunological Methods, 277 (1). 01-10.
 
Relation http://dx.doi.org/
http://www.eprints.iicb.res.in/769/